Recombinant Alpha-Thalassemia/Mental Retardation Syndrome, X-Linked (aTRX)

ATR2; MRXS3; RAD54; RAD54L; SHS; XH2; XNP; ZNF-HX; ATP-Dependent Helicase ATRX,X-Linked Helicase II; X-Linked Nuclear Protein; Transcriptional regulator ATRX

  • Recombinant Alpha-Thalassemia/Mental Retardation Syndrome, X-Linked (aTRX) Packages (Simulation)
  • Recombinant Alpha-Thalassemia/Mental Retardation Syndrome, X-Linked (aTRX) Packages (Simulation)
  • RPK248Hu01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Alpha-Thalassemia/Mental Retardation Syndrome, X-Linked (aTRX)

USAGE of the Recombinant Alpha-Thalassemia/Mental Retardation Syndrome, X-Linked (aTRX)

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Alpha-Thalassemia/Mental Retardation Syndrome, X-Linked (aTRX)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Alpha-Thalassemia/Mental Retardation Syndrome, X-Linked (aTRX)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPK248Hu02 Recombinant Alpha-Thalassemia/Mental Retardation Syndrome, X-Linked (aTRX) Positive Control; Immunogen; SDS-PAGE; WB.
RPK248Hu01 Recombinant Alpha-Thalassemia/Mental Retardation Syndrome, X-Linked (aTRX) Positive Control; Immunogen; SDS-PAGE; WB.
GUESTBOOK